Cellular signalling by lipoproteins in cultured smooth muscle cells from spontaneously hypertensive rats.
We investigated pivotal signalling responses of cultured aortic smooth muscle cells (VSMC) from the spontaneously hypertensive rat (SHR) and the normotensive Wistar Kyoto rat (WKY) to lipoproteins. Low-density lipoprotein (LDL) and high-density lipoprotein (HDL3) stimulated a time- and dose-dependent accumulation of inositol phosphates in VSMC. SHR and WKY VSMC exhibited comparable half-maximal dose requirements (approximately 13 micrograms/ml for LDL and approximately 14 micrograms/ml for HDL3), although, at any given dose, the response of SHR VSMC was significantly greater than WKY VSMC. Simultaneous addition of LDL and HDL3 to VSMC resulted in additive stimulatory effects on phosphoinositide catabolism. Pertussis toxin pretreatment of VSMC completely negated the stimulatory effects of LDL and HDL3 on IP accumulation. [32P]-ADP ribosylation and immunoblotting studies revealed the guanine nucleotide-binding (G protein) substrate(s) for pertussis toxin to be a Gi protein(s). SHR and WKY VSMC did not differ with respect to levels of Gi alpha or G beta, and thus, the amplified responsiveness in SHR VSMC cannot be attributed to alterations in levels of pertussis toxin-sensitive G protein. The spectrum of signalling responses elicited by LDL and HDL3 are similar to those elicited by vasoactive hormones, and thus lipoproteins may, via stimulation of phosphoinositide catabolism, 45Ca2+ uptake and Na+/H(+)-exchange, directly regulate smooth muscle cell growth and contraction.
Department of Research, Basel University Hospital, Switzerland.
T J
TJ
Resink
V
V
Rybin
J
J
Bernhardt
S
S
Orlov
F R
FR
Bühler
V A
VA
Tkachuk
D000818:Animals; D004305:Dose-Response Relationship, Drug; D019204:GTP-Binding Proteins / Q000378:metabolism; D007295:Inositol Phosphates / Q000378:metabolism; D008074:Lipoproteins / Q000494:pharmacology / Q000502:physiology*; D008075:Lipoproteins, HDL / Q000494:pharmacology; D008077:Lipoproteins, LDL / Q000494:pharmacology; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D037342:Pertussis Toxin; D010716:Phosphatidylinositols / Q000378:metabolism; D051381:Rats; D011918:Rats, Inbred SHR / Q000502:physiology*; D011921:Rats, Inbred WKY; D015398:Signal Transduction; D013379:Substrate Specificity; D010566:Virulence Factors, Bordetella / Q000378:metabolism
D007295:Inositol Phosphates; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D010716:Phosphatidylinositols; D010566:Virulence Factors, Bordetella; D037342:Pertussis Toxin; D019204:GTP-Binding Proteins